 |
|
Opiates better than sedatives for treating newborns in withdrawal
July 27, 2005For years, sedatives have been the gold standard for treating newborns suffering from opiate withdrawal. However, new research suggests that opiates themselves are superior to sedatives for treating infants born to women who used heroin or methadone while pregnant.
Opiates appear to better "ameliorate the withdrawal, facilitate feeding and potentially reduce the likelihood of seizures," according to two new systematic reviews done by David Osborn, a neonatologist at the Royal Prince Alfred Hospital in Sydney, Australia, and colleagues.
The researchers also found that infants treated with opiates regained birth weight more quickly than those who only received supportive care.
According to their analysis, the use of opiates instead of sedatives or supportive care alone shortens the duration of supportive care by an average of four days. When compared to diazepam (Valium), opiates reduce the incidence of treatment failure.
However, infants treated with opiates had longer hospital stays than those treated with phenobarbitone, the sedative most often used in these cases. When sedatives only were compared, phenobarbitone was more likely than diazepam to reduce treatment failure.
The reviews appear in the July issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
The reviews included 13 studies with a total of 890 infants of mothers who had used opiates with or without other drugs (including antidepressants, sleep aids and marijuana) during pregnancy. Researchers say two of the studies may have included identical patients.
Newborns suffering from neonatal abstinence syndrome (NAS) exhibit seizures, poor feeding, diarrhea and vomiting that lead to excessive weight loss and dehydration, sleeping problems and fever. Disruption in the mother-child bonding process has also been reported, and there is an increased risk of sudden infant death syndrome.
In the studies, newborns suffering from NAS were treated with opiates (morphine, methadone, paregoric, or tincture of opium), sedatives (phenobarbitone, diazepam or chlorpromazine) or supportive care only. None of the studies compared opiate treatment with placebo.
Of the randomized and "quasi-random" studies analyzed, "the evidence is not high quality," Osborn says, and unanswered questions remain. For example, in infants treated with an opiate, the addition of phenobarbitone may reduce withdrawal severity, but more research is needed using a higher initial dose of opiate, and to examine the effects of phenobarbitone on infant development.
In the 1999 U.S. National Household Survey on Drug Abuse, 3.4 percent of pregnant women reported illicit drug use in the past month, which according to authors represents some 3,000 current pregnant heroin users in the U.S., similar to Australian figures. Between 48 percent and 94 percent of infants exposed to opiates in the uterus develop clinical signs of withdrawal
"The interesting information," Osborn says, "suggests that these infants can be treated without admission to the special care nursery unless withdrawal is complicated and that this is facilitated by use of morphine instead of phenobarbitone. This helps keep mothers and babies together, helps in educating the mothers in mothercraft skills and to recognize signs of infant withdrawal, and helps in assessment of the quality of the mother-infant interaction in a supervised environment."
Center for the Advancement of Health
According to their analysis, the use of opiates instead of sedatives or supportive care alone shortens the duration of supportive care by an average of four days. When compared to diazepam (Valium), opiates reduce the incidence of treatment failure.
However, infants treated with opiates had longer hospital stays than those treated with phenobarbitone, the sedative most often used in these cases. When sedatives only were compared, phenobarbitone was more likely than diazepam to reduce treatment failure.
The reviews appear in the July issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
The reviews included 13 studies with a total of 890 infants of mothers who had used opiates with or without other drugs (including antidepressants, sleep aids and marijuana) during pregnancy. Researchers say two of the studies may have included identical patients.
Newborns suffering from neonatal abstinence syndrome (NAS) exhibit seizures, poor feeding, diarrhea and vomiting that lead to excessive weight loss and dehydration, sleeping problems and fever. Disruption in the mother-child bonding process has also been reported, and there is an increased risk of sudden infant death syndrome.
In the studies, newborns suffering from NAS were treated with opiates (morphine, methadone, paregoric, or tincture of opium), sedatives (phenobarbitone, diazepam or chlorpromazine) or supportive care only. None of the studies compared opiate treatment with placebo.
Of the randomized and "quasi-random" studies analyzed, "the evidence is not high quality," Osborn says, and unanswered questions remain. For example, in infants treated with an opiate, the addition of phenobarbitone may reduce withdrawal severity, but more research is needed using a higher initial dose of opiate, and to examine the effects of phenobarbitone on infant development.
In the 1999 U.S. National Household Survey on Drug Abuse, 3.4 percent of pregnant women reported illicit drug use in the past month, which according to authors represents some 3,000 current pregnant heroin users in the U.S., similar to Australian figures. Between 48 percent and 94 percent of infants exposed to opiates in the uterus develop clinical signs of withdrawal
"The interesting information," Osborn says, "suggests that these infants can be treated without admission to the special care nursery unless withdrawal is complicated and that this is facilitated by use of morphine instead of phenobarbitone. This helps keep mothers and babies together, helps in educating the mothers in mothercraft skills and to recognize signs of infant withdrawal, and helps in assessment of the quality of the mother-infant interaction in a supervised environment."
Center for the Advancement of Health
Opiates Current Events and Opiates News RSSCommon pain relief medication may encourage cancer growth
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
Nation's leading experts on substance abuse outline new research agenda
With substance abuse now accounting for one in 14 hospital admissions and generating billions in health care costs, leading scientists held a briefing on Capitol Hill today to present the evidence that we already have and the evidence we need in treating and preventing the use and abuse of alcohol, drugs and tobacco.
Study finds US prison system falls short in treating drug addiction
Almost a quarter of a million individuals addicted to heroin are incarcerated in the United States each year. However, many prison systems across the country still do not offer medical treatment for heroin and opiate addiction, despite the demonstrated social, medical and economic benefits of opiate replacement therapy (ORT).
Flipping the brain's addiction switch without drugs
When someone becomes dependent on drugs or alcohol, the brain's pleasure center gets hijacked, disrupting the normal functioning of its reward circuitry.
Suppressing the compulsion to steal
If a drug took the fun out of stealing, would it reduce crime? A new study scheduled for the April 1st issue of Biological Psychiatry, published by Elsevier, suggests that this may be so.
Study first to pinpoint why analgesic drugs may be less potent in females than in males
Investigators at Georgia State University's Neuroscience Institute and Center for Behavioral Neuroscience are the first to identify the most likely reason analgesic drug treatment is usually less potent in females than males.
Methamphetamine abuse linked to underage sex, smoking and drinking
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded.
Major study of opiate use in children's hospitals provides simple steps to alleviate harm
Hospitalized kids with painful ailments from broken bones to cancer are often dosed with strong, painkilling drugs known as opiates.
Nature or Nurture-Are You Who Your Brain Chemistry Says You Are?
Researchers using positron emission tomography (PET) have validated a long-held theory that individual personality traits-particularly reward dependency-are connected to brain chemistry, a finding that has implications for better understanding and treating substance abuse and other addictive behaviors.
Medicinal marijuana effective for neuropathic pain in HIV
In a double-blind, placebo-controlled clinical trial to assess the impact of smoked medical cannabis, or marijuana, on the neuropathic pain associated with HIV, researchers at the University of California, San Diego School of Medicine found that reported pain relief was greater with cannabis than with a placebo.
More Opiates Current Events and Opiates News Articles
 |
Romancing Opiates, Revised Paperback Edition: Pharmacological Lies and the Addiction Bureaucracy by Theodore Dalrymple (Author) For hundreds of years, addiction to drugs has seemed dangerous but with a hint of glamour. Addicts are a mystery to those who have never been one. They are presumed to be in touch with profound enlightenments of which non-addicts are ignorant. Theodore Dalrymple shows that doctors, psychologists, and social workers have always known these drug addictions to be false! They have created these myths to build lucrative method of expensive quasi-treatment. |
 |
Opiate by Tool Australian Re-issue, featuring Seven Tracks Including Sweat, Hush, Part of Me, Cold and Ugly (Live), Jerk off (Live), Opiate, and Gaping Lotus. |
 |
Addiction and Opiates by Alfred Lindesmith (Author) This classic study is concerned with addiction to opiate-type drugs and their synthetic equivalents. Lindesmith proposes and systematically elaborates a rational, general theoretical account of the nature of the experiences which generate the addict's characteristic craving for drugs. While this theoretical position has obvious implications for addictions that resemble opiate addiction in that they also involve drugs which produce physical dependence and withdrawal distress, the author does not extend the theory to these other forms of addiction, such as alcoholism.The central theoretical problem is posed by the fact that some persons who experience the effects of opiate-type drugs and use them for a period sufficient to establish physical dependence do not become addicts, while others... |
 |
Dark Paradise: A History of Opiate Addiction in America by David T. Courtwright (Author) In a newly enlarged edition of this eye-opening book, David T. Courtwright offers an original interpretation of a puzzling chapter in American social and medical history: the dramatic change in the pattern of opiate addiction--from respectable upper-class matrons to lower-class urban males, often with a criminal record. Challenging the prevailing view that the shift resulted from harsh new laws, Courtwright shows that the crucial role was played by the medical rather than the legal profession. Dark Paradise tells the story not only from the standpoint of legal and medical sources, but also from the perspective of addicts themselves. With the addition of a new introduction and two new chapters on heroin addiction and treatment since 1940, Courtwright has updated this compelling work of... |
 |
Opiate Sun by Jesu Opiate Sun will be released in the US and UK on Mark Kozelek's Caldo Verde Records home of Mark's own Sun Kil Moon and other transformative musical endeavors. Mark was captured by the strength of Justin's performance when he saw him live in San Francisco in 2007. Therefore he was only too happy to help out when the opportunity arose to be involved in this important project. |
 |
The History of Drugs - Opiates by Nancy Harris (Editor) Since prehistoric times, opiates have been used in religious practices, medicinally, and in food preparation. However, this class of drugs is extremely addictive and has been the cause of legislative battles and wars. Authors in this anthology discuss the development and history of opiates, including morphine, heroin, and Oxycontin. The controversies over international opiate smuggling, drug abuse, and, addiction treatment are also highlighted. |
 |
Burn You Down Opiate For The Masses (Primary Contributor) |
 |
Manifesto by Opiate for the Masses |
 |
HairConfirm Prescription HairConfirm- Hair Follicle 12 Panel Drug Test (including prescription drugs)- Detecting for Marijuana, Amphetamines, Cocaine, Methamphetamine, Opiates, Phencyclidine, Vicodin, Lorcet, Oxycotin, Percocet, Dilaudid by Confirm BioSciences HairConfirm® with Prescription Drugs is the newest addition to the HairConfirm product range. It has all the features and benefits of HairConfirm® and screens for three Prescription Drugs (Hydrocodone, Oxycodone and Hydromorphone) as well as the five popular drug classes as mandated by the Federal Government. |
 |
6 Drug Test for Marijuana/Cocaine/Opiates/Methamphetamine/Benzo by USHealthTests.com This easy to use 6-drug test detects all the major drugs of abuse. The instructions are clear, its easy to use, and extremely accurate: like having a drug testing lab in your home. |
| © 2009 BrightSurf.com |